News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Macrae Sandy
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| Macrae Sandy (President, CEO and Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 10,411 shares
@ $1.33, valued at
$13.8k
|
|
| 03/06/2023 |
4
| Macrae Sandy (President, CEO and Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 157,300 shares
@ $0
Paid exercise price by delivering 54,767 shares
@ $2.66, valued at
$145.7k
Granted 734,050 options to buy
@ $2.66, valued at
$2M
|
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Macrae Sandy (President and CEO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 3,977 shares
@ $14.95, valued at
$59.5k
|
|
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2020 |
4
| Macrae Sandy (President and CEO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 4,283 shares
@ $7.5, valued at
$32.1k
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2018 |
4
| Macrae Sandy (President, CEO and Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 31,500 shares
@ $0
Granted 189,000 options to buy
@ $20.05, valued at
$3.8M
|
|
| 01/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2016 |
4
| Macrae Sandy (President and CEO) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Granted 700,000 options to buy
@ $7.07, valued at
$4.9M
|
|
|
|